Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_assertion type Assertion NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_head.
- NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_assertion description "[8p11 myeloproliferative syndrome (EMS) is a hematopoietic stem cell disorder characterized by myeloid hyperplasia and non-Hodgkin's lymphoma with chromosomal translocations fusing several genes, most commonly ZNF198, to fibroblast growth factor receptor-1 (FGFR1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_provenance.
- NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_assertion evidence source_evidence_literature NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_provenance.
- NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_assertion SIO_000772 15050920 NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_provenance.
- NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_assertion wasDerivedFrom befree-20140225 NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_provenance.
- NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_assertion wasGeneratedBy ECO_0000203 NP624063.RAt0FXJi9u-Ghz1qBtE3z6vs0T35vseCIF0V-ob2CZMXE130_provenance.